Literature DB >> 11009146

Carriage of serogroup W-135, ET-37 meningococci in The Gambia: implications for immunisation policy?

J M MacLennan, R Urwin, S Obaro, D Griffiths, B Greenwood, M C Maiden.   

Abstract

We found high levels of symptomless carriage of a hyperinvasive Neisseria meningitidis strain (electrophoretic type 37 [ET-37], serogroup W-135) during a vaccine trial in Gambian children in 1996. Serogroup C, ET-37 complex meningococci cause 30-40% of meningococcal disease in countries such as the UK, and have a point prevalence of 0.5-1.0%. The recent Haj-associated spread of serogroup W-135, ET-37 complex meningococci, which has been accompanied by numerous secondary cases, might be explained by the apparently raised carriage rates reported here.

Entities:  

Keywords:  Africa; Africa South Of The Sahara; Biology; Central Nervous System; Central Nervous System Effects; Clinical Research; Clinical Trials; Cohort Analysis; Developing Countries; English Speaking Africa; Gambia; Physiology; Research Methodology; Research Report; Vaccines; Western Africa

Mesh:

Substances:

Year:  2000        PMID: 11009146     DOI: 10.1016/S0140-6736(00)02734-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  6 in total

1.  Few university students from overseas have been vaccinated against meningococcal infection.

Authors:  M R Edmunds; J E Davidson; A L Wood; V Raichura
Journal:  BMJ       Date:  2001-01-13

2.  Distribution of serogroups and genotypes among disease-associated and carried isolates of Neisseria meningitidis from the Czech Republic, Greece, and Norway.

Authors:  Siamak P Yazdankhah; Paula Kriz; Georgina Tzanakaki; Jenny Kremastinou; Jitka Kalmusova; Martin Musilek; Torill Alvestad; Keith A Jolley; Daniel J Wilson; Noel D McCarthy; Dominique A Caugant; Martin C J Maiden
Journal:  J Clin Microbiol       Date:  2004-11       Impact factor: 5.948

3.  Epidemiology, molecular characterization and antibiotic resistance of Neisseria meningitidis from patients ≤15 years in Manhiça, rural Mozambique.

Authors:  Ana Belén Ibarz-Pavón; Luis Morais; Betuel Sigaúque; Inacio Mandomando; Quique Bassat; Ariel Nhacolo; Llorenç Quintó; Montse Soriano-Gabarró; Pedro L Alonso; Anna Roca
Journal:  PLoS One       Date:  2011-06-10       Impact factor: 3.240

4.  Genomic characterization of novel Neisseria species.

Authors:  Kanny Diallo; Jenny MacLennan; Odile B Harrison; Chisomo Msefula; Samba O Sow; Doumagoum M Daugla; Errin Johnson; Caroline Trotter; Calman A MacLennan; Julian Parkhill; Ray Borrow; Brian M Greenwood; Martin C J Maiden
Journal:  Sci Rep       Date:  2019-09-24       Impact factor: 4.379

5.  Persistence of W135 Neisseria meningitidis carriage in returning Hajj pilgrims: risk for early and late transmission to household contacts.

Authors:  Annelies Wilder-Smith; Timothy M S Barkham; Sindhu Ravindran; Arul Earnest; Nicholas I Paton
Journal:  Emerg Infect Dis       Date:  2003-01       Impact factor: 6.883

6.  Serogroup W meningococcal disease: global spread and current affect on the Southern Cone in Latin America.

Authors:  R Abad; E L López; R Debbag; J A Vázquez
Journal:  Epidemiol Infect       Date:  2014-05-15       Impact factor: 4.434

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.